Axogen Inc vs IONQ Inc — how do they compare? Axogen Inc trades at $39.4 (market cap $2.06B), while IONQ Inc trades at $39.93 (market cap $14.67B). The key difference: IONQ Inc is far larger — about 7.1× Axogen Inc's market cap, and Axogen Inc is trading nearer its 52-week high, IONQ Inc nearer its low. Which is the better fit depends on your goals.
| AXGN | IONQ | |
|---|---|---|
Market Cap | $2.06B | $14.67B |
Sector | Technology | Technology |
52-Week High | $46.19 | $82.09 |
52-Week Low | $11.28 | $26.59 |
Enterprise Value | $1.98B | $12.66B |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
IONQ shares declined 9.29% to $38.88 amid broader quantum computing sector weakness, though technical indicators show oversold conditions with RSI at 16.05. The company maintains a mixed fundamental picture with strong revenue growth projections ($130M in 2025 to $187M in 2026) but significant operating losses. Analyst sentiment remains divided with a 50/50 buy/hold split despite a consensus price target of $73.75 representing 90% upside potential from current levels.
The stock presents high-risk, high-reward potential with Wall Street recognizing IONQ's leadership in trapped-ion quantum computing technology but concerned about cash burn and execution risks. Near-term catalysts include Q2 2026 earnings and the planned 256-qubit system demonstration, though the stock faces volatility from speculative trading and competitive pressures in the emerging quantum sector.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →